XML 30 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Mar. 31, 2015
Mar. 31, 2014
Revenues:        
License and milestone fees $ 5,078imgn_LicenseAndMilestoneFees $ 305imgn_LicenseAndMilestoneFees $ 52,729imgn_LicenseAndMilestoneFees $ 39,150imgn_LicenseAndMilestoneFees
Royalty revenue 5,099us-gaap_RoyaltyRevenue 2,558us-gaap_RoyaltyRevenue 13,890us-gaap_RoyaltyRevenue 6,946us-gaap_RoyaltyRevenue
Research and development support 532imgn_ResearchAndDevelopmentRevenue 1,948imgn_ResearchAndDevelopmentRevenue 2,140imgn_ResearchAndDevelopmentRevenue 5,860imgn_ResearchAndDevelopmentRevenue
Clinical materials revenue 718us-gaap_ReimbursementRevenue 2,064us-gaap_ReimbursementRevenue 4,171us-gaap_ReimbursementRevenue 2,197us-gaap_ReimbursementRevenue
Total revenues 11,427us-gaap_Revenues 6,875us-gaap_Revenues 72,930us-gaap_Revenues 54,153us-gaap_Revenues
Operating Expenses:        
Research and development 25,666us-gaap_ResearchAndDevelopmentExpense 38,280us-gaap_ResearchAndDevelopmentExpense 81,331us-gaap_ResearchAndDevelopmentExpense 81,171us-gaap_ResearchAndDevelopmentExpense
General and administrative 7,000us-gaap_GeneralAndAdministrativeExpense 6,040us-gaap_GeneralAndAdministrativeExpense 20,967us-gaap_GeneralAndAdministrativeExpense 18,013us-gaap_GeneralAndAdministrativeExpense
Total operating expenses 32,666us-gaap_OperatingExpenses 44,320us-gaap_OperatingExpenses 102,298us-gaap_OperatingExpenses 99,184us-gaap_OperatingExpenses
Loss from operations (21,239)us-gaap_OperatingIncomeLoss (37,445)us-gaap_OperatingIncomeLoss (29,368)us-gaap_OperatingIncomeLoss (45,031)us-gaap_OperatingIncomeLoss
Other (expense) income, net (379)us-gaap_OtherNonoperatingIncomeExpense (7)us-gaap_OtherNonoperatingIncomeExpense (897)us-gaap_OtherNonoperatingIncomeExpense 166us-gaap_OtherNonoperatingIncomeExpense
Net loss (21,618)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic (37,452)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic (30,265)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic (44,865)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
Basic and diluted net loss per common share (in dollars per share) $ (0.25)us-gaap_EarningsPerShareBasicAndDiluted $ (0.44)us-gaap_EarningsPerShareBasicAndDiluted $ (0.35)us-gaap_EarningsPerShareBasicAndDiluted $ (0.53)us-gaap_EarningsPerShareBasicAndDiluted
Basic and diluted weighted average common shares outstanding (in shares) 86,080us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 85,684us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 85,962us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 85,375us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted
Total comprehensive loss $ (21,618)us-gaap_ComprehensiveIncomeNetOfTax $ (37,452)us-gaap_ComprehensiveIncomeNetOfTax $ (30,265)us-gaap_ComprehensiveIncomeNetOfTax $ (44,865)us-gaap_ComprehensiveIncomeNetOfTax